Skip to main content

Table 1 Clinical, demographic and investigational characteristics of the study groups

From: Efficacy and safety of hydro-mechanical defragmentation in intermediate- and high-risk pulmonary embolism

Characteristics

Group A (HMD)

Group B (ST)

p value

No. 25

No. 25

Age (range) year

49.6 ± 13.13 (26–68)

42.92 ± 12.3 (28–80)

0.070

Female gender (%)

13 (52%)

17 (68%)

0.248

Risk factor for pulmonary embolism

   

 Major surgery

6 (24%)

10 (40%)

0.363

 Fracture

6 (24%)

3 (12%)

0.462

 Cancer

3 (12%)

1 (4%)

0.602

 Paraplegia

1 (4%)

0 (0%)

1.000

 Contraceptive pills

3 (12%)

4 (16%)

1.000

 Stroke

0 (0%)

2 (8%)

0.470

 Unknown

6 (24%)

5 (20%)

1.000

CTPA results on admission (%)

   

 Bilateral main PE

21 (84%)

17 (68%)

0.069

 Saddle shaped PE

4 (16%)

2 (8%)

 Right main PE

0

4 (16%)

 Left main PE

0

2 (8%)

Echocardiography (%)

  

0.97

 Dilated right side

25 (100%)

25 (100%)

0.069

 60/60 sign

25 (100%)

25 (100%)

 McConnell sign

25 (100%)

25 (100%)

Type of pulmonary embolism(%)

   

 High-risk PE

17 (68%)

17 (68%)

0.989

 Intermediate-high-risk PE

8 (32%)

8 (32%)

Procedure done (%)

   

 Fragmentation only

10 (40%)

0

 

 Fragmentation and local thrombolysis

9 (36%)

0

 Fragmentation and local thrombolysis after failure of ST

6 (24%)

0

  1. Data are presented as mean ± standard deviation or number and percent. HMD = hydro-mechanical defragmentation; ST = systemic thrombolysis; PE = pulmonary embolism; CTPA = computed tomography pulmonary angiography; yr. = years
  2. *Statistically significant difference (p < 0.05); **Highly statistically significant difference (p < 0.01)